Immuno-oncology is a promising treatment approach that stimulates the immune system to detect and attack cancer cells. “We’ve seen an initial wave of checkpoint inhibitors and systemic agents ...

The presence of microplastics in our food and soil has become a global-level crisis. A young girl named Anushka Sable has ...

Dendritic cells (DC) offer hope that the treatment of end-stage cancer will become much more successful in the near future.

This study reports the molecular features and interactions of tumor and immune cells associated with two craniopharyngioma subtypes that will help identify future targeted therapeutics.

The new technique could kill a wide range of cancer cells, including breast and prostate A newly-discovered part of our immune system could be harnessed to treat all cancers, say scientists.

This therapy is the first to activate specific components of the adaptive immune system, particularly CD4+ T helper cells, which are not known to be involved in traditional cancer treatments.

Hypoxia contributes to cancer resistance to both standard therapies and immunotherapy. This work demonstrates that tumor ...

exerts dual effects on the tumor microenvironment (TME), necessitating integration with systemic therapies like immune checkpoint inhibitors (ICIs). Yet, therapeutic resistance, hypoxia-induced ...

a B7 family molecule associated with tumor immune evasion by induction of apoptosis in activated tumor-reactive T cells, is constitutively expressed on two-thirds of cases of SCC of the head and ...